01 1Merck Group
01 1TRISODIUM CITRATE DIHYDRATE
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-30
Pay. Date : 2016-11-01
DMF Number : 29906
Submission : 2015-12-07
Status : Active
Type : II
20
Merck Kgaa, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRISODIUM CITRATE DIHYDRATE, with a corresponding US DMF Number 29906.
Remarkably, this DMF maintains an Active status since its submission on December 07, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 30, 2017, and payment made on November 01, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
